Health

STAT+: Up and down the ladder: The latest comings and goings

Read full article at source ↗

Based on a feed excerpt; full article content has not been acquired. Source evidence retrieved 30/10/2026, 14:51:24 UTC.

Briefings

STAT+ reports that Vir Biotechnology hired David Liu as chief medical officer, a move following his tenure at Nuvation Bio. The article highlights the company's strategy of promoting internal talent, though it notes that such changes can sometimes lead to a lack of engagement. The report serves as a regular feature highlighting personnel shifts within the biotech sector.

Key points

• Vir Biotechnology hired David Liu as chief medical officer, a role previously held at Nuvation Bio.
• The article notes that promoting internal talent can sometimes result in a lack of engagement among staff.

Context

STAT+ features a weekly highlight of personnel changes within the biotech industry, specifically focusing on Vir Biotechnology's recent hiring of David Liu as chief medical officer.

Limitations

The evidence is limited to a single sentence describing the hiring event. No specific dates, salary figures, or performance metrics are provided. The article does not offer any analysis of the impact of this hire or future plans.

Generated by Bittrees-hosted qwen35-2b sha256:aaf42c8b7c3c on 30/10/2026, 16:30:34 UTC. Based on publisher-provided feed evidence; may not cover the full original article. Check the source for details.

View archived briefing on IPFS
bafybeih7uj7pzspsy7pz37fyfgn32vvfap23r4dnwglfbtlr2yq2uibgcq